EQUITY |
9 Months Ended |
|---|---|
May 31, 2017 | |
| Equity [Abstract] | |
| EQUITY |
NOTE 6 - EQUITY
Authorized Stock
On January 19, 2017, a majority of stockholders of our company and our board of directors approved a change of name of our company from Knight Knox Development Corp. to Reactive Medical Inc. and an increase to our authorized capital from 75,000,000 shares of common stock, par value $0.001 to 150,000,000 shares of common stock, par value $0.001 and 50,000,000 shares of preferred stock, par value $0.001.
Preferred shares
The Company has authorized 50,000,000 shares of preferred stock with a par value of $0.001.
During the nine months ended May 31, 2017, there were no issuances of preferred stock.
Common Shares
The Company has authorized 150,000,000 common shares with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.
During the nine months ended May 31, 2017, the Company issued 2,160,000 common shares, par value $0.001 for proceeds of $2,160. |